Skip to main content
Premium Trial:

Request an Annual Quote

Neurocrine Licenses Genedata s Expressionist for Biomarker Discovery

NEW YORK, Dec. 7, (GenomeWeb News) - Biopharmaceutical company Neurocrine Biosciences has licensed Genedata's Expressionist for biomarker discovery and in silico prediction, Genedata said today.

 

Neurocrine will use Expressionist in a pre-clinical discovery program focusing on neurological and endocrine related diseases and disorders, Genedata said.

 

Scientists at Neurocrine have already used Expressionist to process and evaluate over 1,500 microarrays, said Bill Wilson, Neurocrine's head of information technology, in a statement.

 

Financial details were not disclosed.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.